Akihiro Tanemura

Akihiro Tanemura

Auto-generated profile, based on publicly available information

Akihiro Tanemura

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2020 in BMC Surgery
Verified
Journal Article
Open access
PDF file
ATAkihiro Tanemura
Akihiro Tanemura
SMShugo Mizuno
Shugo Mizuno
AHAoi Hayasaki
Aoi Hayasaki
KGKazuyuki Gyoten
Kazuyuki Gyoten
TFTakehiro Fujii
Takehiro Fujii
SIShuji Isaji
Shuji Isaji
Background: Several inflammation-based scores are used to assess the surgical outcomes of hepatocellular carcinoma (HCC). The aim of the present study was to elucidate the prognostic value of the prognostic nutritional index (PNI) in HCC patients who underwent hepatectomy with special attention to preoperative liver functional reserve. Methods: Preoperative demographic and tumor-related factors were analyzed in 189 patients with HCC undergoing initial hepatectomy from August 2005 to May 2016 to identify significant prognostic factors. Results: Multivariate analysis for overall survival (OS) revealed that female sex (p = 0.005), tumor size (p < 0.001) and PNI (p = 0.001) were independent prognostic factors. Compared to the High PNI group (PNI ≥ 37, n = 172), the Low PNI group (PNI < 37, n = 17) had impaired liver function and significantly poorer OS (13% vs. 67% in 5-year OS, p = 0.001) and recurrence-free survival (RFS) (8 vs. 25 months in median PFS time, p = 0.002). In the subgroup of patients with a preserved liver function of LHL15 ≥ 0.9, PNI was also independent prognostic factor, and OS (21% vs. 70% in 5-year OS, p = 0.008) and RFS (8 vs. 28 months in median PFS time, p = 0.018) were significantly poorer in the Low PNI group than the High PNI group. Conclusions: PNI was an independent prognostic factor for HCC patients who underwent hepatectomy. Patients with PNI lower than 37 were at high risk for early recurrence and poor patient survival, especially in the patients with preserved liver function of LHL ≥ 0.9.

29 October 2024 in BMC Surgery
Verified
Journal Article
Open access
PDF file
ATAkihiro Tanemura
Akihiro Tanemura
DNDaisuke Noguchi
Daisuke Noguchi
TSToru Shinkai
Toru Shinkai
TITakahiro Ito
Takahiro Ito
AHAoi Hayasaki
Aoi Hayasaki
SMShugo Mizuno
Shugo Mizuno
In hepatocellular carcinoma (HCC), postoperative recurrence remains high. This study aimed to evaluate the recurrence patterns and prognosis of HCC after curative hepatectomy. Among 352 patients with primary HCC who underwent initial hepatectomy between January 2002 and December 2022, 151 with recurrence were assessed for the relationship between recurrence pattern and prognosis. The early recurrence group (within 6 months postoperatively; n = 38) had significantly higher serum alpha-fetoprotein (p = 0.002), des-γ-carboxyprothrombin (DCP; p = 0.004) levels and Barcelona Clinic Liver Cancer (BCLC) stage (p < 0.001), larger tumor size (p < 0.001), higher incidence of multiple tumors (p = 0.002) and lower overall survival (OS) (p < 0.001) than the late recurrence group (> 6 months postoperatively; n = 113). The tumor size (p = 0.013) and BCLC stage (p = 0.001) were independent risk factors for early recurrence within 6 months in multivariate analysis. The multiple recurrence group (intrahepatic multinodular recurrence or distant metastasis; n = 89) had significantly lower prognostic nutritional index (p = 0.026), larger tumor size (p = 0.017), lower incidence of liver cirrhosis (p = 0.03) than the single recurrence group (single nodule recurrence; n = 62). The multiple recurrence group, especially patients with ≥ three intrahepatic nodules and distant metastases, had lower postoperative OS (p < 0.001) and shorter time to recurrence (p < 0.001) than the single recurrence group. When the patients were classified into three groups: late recurrence with one or two tumors (Group A; n = 74), early recurrence or three or more tumors or distant metastasis (Group B; n = 54), and early recurrence with three or more tumors or distant metastasis (Group C; n = 23), OS was significantly lower in Groups B and C than Group A (p < 0.001). Patients with early recurrence within 6 months after surgery and three or more recurrence nodule or distant metastasis exhibited poor prognosis after initial recurrence, and they should be carefully followed up.

1 May 2014 in Transplantation Proceedings
Verified
Journal Article
Closed access
ATA. Tanemura
A. Tanemura
NKN. Kuriyama
N. Kuriyama
YAY. Azumi
Y. Azumi
IOI. Ohsawa
I. Ohsawa
MKM. Kishiwada
M. Kishiwada
SIS. Isaji
S. Isaji

1 November 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
ATA. Tanemura
A. Tanemura
SMS. Mizuno
S. Mizuno
AHA. Hayasaki
A. Hayasaki
TFT. Fujii
T. Fujii
YIY. Iizawa
Y. Iizawa
SIS. Isaji
S. Isaji


11 November 2012 in Surgery Today
Verified
Journal Article
Closed access
PDF file
ATAkihiro Tanemura
Akihiro Tanemura
SMShugo Mizuno
Shugo Mizuno
YOYasuo Okura
Yasuo Okura
HIHiroyuki Inoue
Hiroyuki Inoue
HTHaruyuki Takaki
Haruyuki Takaki
SIShuji Isaji
Shuji Isaji